Delivery Order SPE2DB22D2006-SPE2DB24FV8DW
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Venofer 100 mg/5 ml vials, a pharmaceutical product. The contract has a firm-fixed price of $2,689.21 and a completion date of May 21, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $3,171.01 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venofer 100 mg/5 ml vials, a medication used to treat iron deficiency anemia. The contract is not designated as a set-aside and has an ultimate completion date of March 7, 2025. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,001.67, is for the delivery of Venofer 100 mg/5 ml vials. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,293.72, is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a medication used in the treatment of iron deficiency anemia. The contract has an ultimate completion date of April 30, 2024. This delivery order is issued under AmerisourceBergen's existing...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venofer 100 mg/5 ml vials, a medication used to treat iron deficiency anemia. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,137.72 and a performance period through January 23, 2024. The contract was awarded on January 22, 2024 and does not have a set-aside...
- The Defense Logistics Agency awarded a $4,091.60 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Venofer (iron sucrose) 100 mg/5 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Venofer is a critical pharmaceutical used for treating iron deficiency anemia, particularly in patients with chronic kidney disease...
- The Defense Logistics Agency awarded a delivery order valued at $2,222.42 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,738.94 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 ml vials. This firm fixed-price delivery order, executed on December 22, 2025, with completion scheduled for December 23, 2025, was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.32 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 20, 2023, with a total ceiling value of $4,239.04. The contract is a Firm Fixed Price Delivery Order with a completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which has a significant Indefinite Delivery...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8DWDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization and leading global pharmaceutical distributor. The contract, valued at $3,927.61, is for the supply of 4,563,667,614 units of the medication Venofer 100 mg/5 ml vial with a 5 ml size. The contract does not have a set-aside designation. In addition to this specific delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 2/14/24 |